Prediction of nodal spread of breast cancer by using artificial neural network-based analyses of S100A4, nm23 and steroid receptor expression

被引:11
作者
Grey, SR
Dlay, SS
Leone, BE
Cajone, F
Sherbet, GV
机构
[1] Newcastle Univ, Sch Elect Engn & Comp Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Osped Monza, Monza, Italy
[3] Univ Milan, Ist Patol Gen, Milan, Italy
[4] Inst Mol Med, Huntington Beach, CA USA
关键词
artificial neural networks; breast cancer; metastasis associated gene; metastasis suppressor gene; nm23; nodal spread prediction; oestrogen receptor; progesterone receptor; S100A4;
D O I
10.1023/A:1025846019656
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The expression of tumour promoter gene S100A4, metastasis suppressor gene nm23, oestrogen and progesterone receptors, and tumour grade and size have been investigated for their potential to predict breast cancer progression. The molecular and cellular data have been analysed using artificial neural networks to determine the potential of these markers to predict the presence of metastatic tumour in the regional lymph nodes. This study shows that tumour grade and size are poor predictors. The relative expression of S100A4 and nm23 genes is the single most effective predictor of nodal status. Inclusion of oestrogen- and progesterone-receptor status with tumour grade and size markers improves prediction; however, there may be some overlap between steroid receptors and molecular markers. This study also underscores the power of artificial neural network techniques to predict the potential of primary breast cancers to spread to axillary lymph nodes. This could aid the clinician in determining whether invasive procedures of axially node dissection can be obviated and whether conservative forms of treatment might be appropriate in the management of the patient.
引用
收藏
页码:507 / 514
页数:8
相关论文
共 52 条
[41]   CHARACTER-RECOGNITION - QUALITATIVE REASONING AND NEURAL NETWORKS [J].
RODIN, EY ;
WU, YL ;
AMIN, SM .
MATHEMATICAL AND COMPUTER MODELLING, 1992, 16 (02) :95-104
[42]   REDUCED NM23 AWD PROTEIN IN TUMOR-METASTASIS AND ABERRANT DROSOPHILA DEVELOPMENT [J].
ROSENGARD, AM ;
KRUTZSCH, HC ;
SHEARN, A ;
BIGGS, JR ;
BARKER, E ;
MARGULIES, IMK ;
KING, CR ;
LIOTTA, LA ;
STEEG, PS .
NATURE, 1989, 342 (6246) :177-180
[43]   NM23 PROTEIN EXPRESSION IN DUCTAL INSITU AND INVASIVE HUMAN BREAST-CARCINOMA [J].
ROYDS, JA ;
STEPHENSON, TJ ;
REES, RC ;
SHORTHOUSE, AJ ;
SILCOCKS, PB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (09) :727-731
[44]  
Seker H, 2002, ANTICANCER RES, V22, P433
[45]   A fuzzy measurement-based assessment of breast cancer prognostic markers [J].
Seker, H ;
Odetayo, M ;
Petrovic, D ;
Naguib, RNG ;
Bartoli, C ;
Alasio, L ;
Lakshmi, MS ;
Sherbet, GV .
2000 IEEE EMBS INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY APPLICATIONS IN BIOMEDICINE, PROCEEDINGS, 2000, :174-178
[46]   Epidermal growth factor receptor status correlates with cell proliferation-related 18A2/mts1 gene expression in human carcinoma cell lines [J].
Sherbet, GV ;
Parker, C ;
Usmani, BA ;
Lakshmi, MS .
CANCER PREVENTION: FROM THE LABORATORY TO THE CLINIC: IMPLICATIONS OF GENETIC, MOLECULAR, AND PREVENTIVE RESEARCH, 1995, 768 :272-276
[47]  
STAHL JA, 1991, CANCER RES, V51, P445
[48]  
STEEG PS, 1990, CLIN EXP METASTAS S1, V8, P16
[49]  
THORPE SM, 1987, CANCER RES, V47, P6126
[50]   REDUCED EXPRESSION OF NM23-H1, BUT NOT OF NM23-H2, IS CONCORDANT WITH THE FREQUENCY OF LYMPH-NODE METASTASIS OF HUMAN BREAST-CANCER [J].
TOKUNAGA, Y ;
URANO, T ;
FURUKAWA, K ;
KONDO, H ;
KANEMATSU, T ;
SHIKU, H .
INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (01) :66-71